Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Drug Therapy, Combination »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Therapy < Drug Therapy, Combination < Drug Tolerance  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 185.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000051 (2021) Victoria Birlutiu ; Rares Mircea Birlutiu ; Liana ChiceaOff-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience.
000055 (2021) Nurullah Okumu ; Ne E Demirtürk ; R Za Aytaç Çetinkaya ; Rahmet Güner ; Smail Ya Ar Avc ; Semiha Orhan ; Petek Konya ; Bengü Aylan ; Ay Egül Karalezli ; Levent Yamanel ; Bircan Kayaaslan ; Gülden Y Lmaz ; Ümit Sava Ç ; Fatma Eser ; Gürhan Ta K NEvaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
000063 (2021) Pravash Budhathoki ; Dhan Bahadur Shrestha ; Sitaram Khadka ; Era RawalIs Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis.
000076 (2021) Álvaro Réa-Neto ; Rafaella Stradiotto Bernardelli ; Bruna Martins Dzivielevski Câmara ; Fernanda Baeumle Reese ; Marcos Vinicius Oliveira Queiroga ; Mirella Cristine OliveiraAn open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients.
000088 (2021) Geoffrey A. Rubin ; Amar D. Desai ; Zilan Chai ; Aijin Wang ; Qixuan Chen ; Amy S. Wang ; Cameron Kemal ; Haajra Baksh ; Angelo Biviano ; Jose M. Dizon ; Hirad Yarmohammadi ; Frederick Ehlert ; Deepak Saluja ; David A. Rubin ; John P. Morrow ; Uma Mahesh R. Avula ; Jeremy P. Berman ; Alexander Kushnir ; Mark P. Abrams ; Jessica A. Hennessey ; Pierre Elias ; Timothy J. Poterucha ; Nir Uriel ; Christine J. Kubin ; Elijah Lasota ; Jason Zucker ; Magdalena E. Sobieszczyk ; Allan Schwartz ; Hasan Garan ; Marc P. Waase ; Elaine Y. WanCardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
000091 (2021) Gilmar Reis ; Eduardo Augusto Dos Santos Moreira Silva ; Daniela Carla Medeiros Silva ; Lehana Thabane ; Gurmit Singh ; Jay J H. Park ; Jamie I. Forrest ; Ofir Harari ; Castilho Vitor Quirino Dos Santos ; Ana Paula Figueiredo Guimarães De Almeida ; Adhemar Dias De Figueiredo Neto ; Leonardo Cançado Monteiro Savassi ; Aline Cruz Milagres ; Mauro Martins Teixeira ; Maria Izabel Campos Simplicio ; Luciene Barra Ribeiro ; Rosemary Oliveira ; Edward J. MillsEffect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial.
000123 (2021) Joshuan J. Barboza ; Diego Chambergo-Michilot ; Mariana Velasquez-Sotomayor ; Christian Silva-Rengifo ; Carlos Diaz-Arocutipa ; Jose Caballero-Alvarado ; Franko O. Garcia-Solorzano ; Christoper A. Alarcon-Ruiz ; Leonardo Albitres-Flores ; German Malaga ; Patricia Schlagenhauf ; Alfonso J. Rodriguez-MoralesAssessment and management of asymptomatic COVID-19 infection: A systematic review.
000194 (2021) Waqas Aslam ; Carla R. Lamb ; Nadia AliTorsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications.
000226 (2021) Mark Stewart ; Carla Rodriguez-Watson ; Adem Albayrak ; Julius Asubonteng ; Andrew Belli ; Thomas Brown ; Kelly Cho ; Ritankar Das ; Elizabeth Eldridge ; Nicolle Gatto ; Alice Gelman ; Hanna Gerlovin ; Stuart L. Goldberg ; Eric Hansen ; Jonathan Hirsch ; Yuk-Lam Ho ; Andrew Ip ; Monika Izano ; Jason Jones ; Amy C. Justice ; Reyna Klesh ; Seth Kuranz ; Carson Lam ; Qingqing Mao ; Samson Mataraso ; Robertino Mera ; Daniel C. Posner ; Jeremy A. Rassen ; Anna Siefkas ; Andrew Schrag ; Georgia Tourassi ; Andrew Weckstein ; Frank Wolf ; Amar Bhat ; Susan Winckler ; Ellen V. Sigal ; Jeff AllenCOVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
000227 (2021) Guillaume Hache ; Jean Marc Rolain ; Philippe Gautret ; Jean-Claude Deharo ; Philippe Brouqui ; Didier Raoult ; Stéphane HonoréCombination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.
000229 (2021) T S Brandon Ng ; Kori Leblanc ; Darwin F. Yeung ; Teresa S M. TsangMedication use during COVID-19: Review of recent evidence.
000233 (2021) Alexis Lacout ; Valere Lounnas ; Christian PerronneTiming and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.
000245 (2021) Hervé SeligmannBalanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment.
000253 (2021) Burcu U Urlu Ilg N ; Rem Müge Akbulut Koyuncu ; Emrullah K Z LtunçEffect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.
000294 (2021) Rahmet Guner ; Imran Hasanoglu ; Bircan Kayaaslan ; Adalet Aypak ; Esragul Akinci ; Hurrem Bodur ; Fatma Eser ; Ayse Kaya Kalem ; Orhan Kucuksahin ; Ihsan Ates ; Aliye Bastug ; Yasemin Tezer Tekce ; Zeynep Bilgic ; Fahriye Melis Gursoy ; Hatice Nisa Akca ; Seval Izdes ; Deniz Erdem ; Emra Asfuroglu ; Habibe Hezer ; Hatice Kilic ; Musa C Vak ; Sibel Aydogan ; Turan BuzganComparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.
000318 (2021) Elisa Baranski Lamback ; Monica Amorim De Oliveira ; Andrea Ferreira Haddad ; André Filipe Marcondes Vieira ; Armando Leão Ferreira Neto ; Taciana Da Silva Maia ; Juliana De Rezende Chrisman ; Pedro Pimenta De Mello Spineti ; Marco Antonio De Mattos ; Eduardo CostaHydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19.
000325 (2021) Masashi Ohe ; Ken Furuya ; Houman GoudarziMultidrug treatment for COVID-19.
000336 (2021) Philippe Gautret ; Van Thuan Hoang ; Philippe Colson ; Didier RaoultEffect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.
000380 (2021) Stéphane Honoré ; Philippe GautretReply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.
000394 (2021) Nathaniel J. Rhodes ; Atheer Dairem ; William J. Moore ; Anooj Shah ; Michael J. Postelnick ; Melissa E. Badowski ; Sarah M. Michienzi ; Jaime L. Borkowski ; Radhika S. Polisetty ; Karen Fong ; Emily S. Spivak ; James R. Beardsley ; Cory M. Hale ; Andrea M. Pallotta ; Pavithra Srinivas ; Lucas T. SchulzMulticenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States.
000402 (2021) Jessica M. Franklin ; Kueiyu Joshua Lin ; Nicolle M. Gatto ; Jeremy A. Rassen ; Robert J. Glynn ; Sebastian SchneeweissReal-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Drug Therapy, Combination" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Drug Therapy, Combination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Drug Therapy, Combination
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021